Your browser doesn't support javascript.
loading
Asthma Cases Treated With Inhaled Anesthetics or Extracorporeal Membrane Oxygenation: A Virtual Pediatric Systems Database Study of Outcomes.
Pineda, Erika Y; Sallam, Mohammad; Breuer, Ryan K; Perez, Geovanny F; Wrotniak, Brian; Swayampakula, Anil Kumar.
Afiliação
  • Pineda EY; Department of Pediatrics, Division of Critical Care Medicine, John R. Oishei Children's Hospital, University at Buffalo, Buffalo, NY.
  • Sallam M; Department of Pediatrics, Boston Children's Hospital, Boston, MA.
  • Breuer RK; Department of Pediatrics, Division of Critical Care Medicine, John R. Oishei Children's Hospital, University at Buffalo, Buffalo, NY.
  • Perez GF; Department of Pediatrics, Division of Pulmonology, John R. Oishei Children's Hospital, University at Buffalo, Buffalo, NY.
  • Wrotniak B; Department of Pediatrics, University at Buffalo, Buffalo, NY.
  • Swayampakula AK; Department of Pediatrics, Division of Critical Care Medicine, John R. Oishei Children's Hospital, University at Buffalo, Buffalo, NY.
Pediatr Crit Care Med ; 24(8): e397-e402, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37092833
ABSTRACT

OBJECTIVES:

Extracorporeal membrane oxygenation (ECMO) and/or inhaled anesthetics (IAs) are considered in the management of asthma when refractory to conventional therapy. We aimed to compare the outcomes of these two modalities in asthma PICU care and determine associated survival to hospital discharge among patients in a United States database.

DESIGN:

Retrospective analysis using the Virtual Pediatric Systems (VPS, LLC) database.

SETTING:

PICUs participating in the VPS database. PATIENTS Patients less than 18 years old with diagnosis of asthma treated with IA and/or ECMO from January 2010 to December 2020.

INTERVENTIONS:

None. MEASUREMENTS AND MAIN

RESULTS:

A total of 221 patients were included; 149 (67%) received ECMO, 62 (28%) received IA, and 10 (5%) received both interventions. We failed to identify any difference between the ECMO and IA groups in demographics, Pediatric Index of Mortality 2 percentage, Pediatric Risk of Mortality 3 score, Pediatric Logistic Organ Dysfunction score, or pre-intervention pH and Pa co2 levels. Use of ECMO versus IA was associated with lower pre-intervention Pa o2 (60 torr [7.99 kPa] vs 78 torr [10.39 kPa]; p < 0.001) and higher utilization of high-frequency oscillatory ventilation. We failed to identify an association between type of intervention (IA vs ECMO) and greater odds of survival (57/62 [92%] vs 128/149 [86%]; odds ratio [OR], 1.87; 95% CI, 0.67-5.21; p = 0.23). However, these data do not exclude the possibility that IA use is associated with more than five-fold greater odds of survival. ECMO use was associated with longer duration of intervention (5 vs 1.3 d; p < 0.001) and PICU length of stay (LOS) (13 vs 7 d; p < 0.001). As expected, ECMO versus IA was also associated with greater odds of undergoing bronchoscopy (34% vs 11%; OR, 3.7; 95% CI, 1.5-9.4; p = 0.004).

CONCLUSIONS:

In the VPS database of asthma management cases, we failed to identify an association between ECMO versus IA use and survival to hospital discharge. However, ECMO was associated with longer duration of intervention and PICU LOS.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Oxigenação por Membrana Extracorpórea Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Oxigenação por Membrana Extracorpórea Idioma: En Ano de publicação: 2023 Tipo de documento: Article